Literature DB >> 12582026

Bulky DNA adducts and risk of cancer: a meta-analysis.

Fabrizio Veglia1, Giuseppe Matullo, Paolo Vineis.   

Abstract

We present a meta-analysis to test the hypothesis that the presence of a high level of bulky DNA adducts in tissues is associated with an increased risk of cancer in humans. Seven articles were selected that matched the selection criteria, for a total of 691 cancer patients and 632 control subjects. In five studies the cases had lung cancer, in one oral cancer, and in one bladder cancer. Six studies measured adducts in WBCs and one in normal lung tissue around tumor tissue. Six were case-control investigations, and one was a case-control study on lung cancer nested within a cohort. Current smokers showed a statistically significant difference between cases and controls, with cases having 83% higher levels of adducts than controls (95% confidence interval, 0.44-1.22). Results were negative or contradictory in ex-smokers and nonsmokers. This observation was confirmed by sensitivity analyses. Publication bias does not seem to be a problem. Despite some methodological limitations, our meta-analysis shows that current smokers with high levels of adducts have an increased risk of lung and bladder cancers. This conclusion also suggests that similar (aromatic) compounds may be involved in the etiology of both types of cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12582026

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  31 in total

1.  White blood cell DNA adducts in a cohort of asthmatic children exposed to environmental tobacco smoke.

Authors:  Stephen E Wilson; Glenn Talaska; Robert S Kahn; Brenda Schumann; Jane Khoury; Anthony C Leonard; Bruce P Lanphear
Journal:  Int Arch Occup Environ Health       Date:  2010-03-25       Impact factor: 3.015

2.  Lack of associations among cancer and albumin adducts, ras p21 oncoprotein levels, and CYP1A1, CYP2D6, NAT1, and NAT2 in a nested case-control study of lung cancer within the physicians' health study.

Authors:  Frederica P Perera; Deliang Tang; Paul Brandt-Rauf; Regina M Santella; La Verne A Mooney; Yi-Hsuan Tu; Ivona Bendkowska; Douglas A Bell
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-07       Impact factor: 4.254

3.  Polycyclic aromatic hydrocarbon- and aflatoxin-albumin adducts, hepatitis B virus infection and hepatocellular carcinoma in Taiwan.

Authors:  Hui-Chen Wu; Qiao Wang; Lian-Wen Wang; Hwai-I Yang; Habibul Ahsan; Wei-Yann Tsai; Li-Yu Wang; Shu-Yuan Chen; Chien-Jen Chen; Regina M Santella
Journal:  Cancer Lett       Date:  2007-01-23       Impact factor: 8.679

4.  Emerging technology in molecular epidemiology: what epidemiologists need to know.

Authors:  Frederica P Perera; Julie B Herbstman
Journal:  Epidemiology       Date:  2008-03       Impact factor: 4.822

5.  Analysis of r-7,t-8,9,c-10-tetrahydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene in human urine: a biomarker for directly assessing carcinogenic polycyclic aromatic hydrocarbon exposure plus metabolic activation.

Authors:  Yan Zhong; Steven G Carmella; J Bradley Hochalter; Silvia Balbo; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2010-11-04       Impact factor: 3.739

Review 6.  Recent advances in the metabolomic study of bladder cancer.

Authors:  Chandra Sekhar Amara; Venkatrao Vantaku; Yair Lotan; Nagireddy Putluri
Journal:  Expert Rev Proteomics       Date:  2019-02-26       Impact factor: 3.940

Review 7.  Heightened susceptibility: A review of how pregnancy and chemical exposures influence maternal health.

Authors:  Julia Varshavsky; Anna Smith; Aolin Wang; Elizabeth Hom; Monika Izano; Hongtai Huang; Amy Padula; Tracey J Woodruff
Journal:  Reprod Toxicol       Date:  2019-05-02       Impact factor: 3.143

8.  Physical activity and lung cancer among non-smokers: a pilot molecular epidemiological study within EPIC.

Authors:  Andrew Rundle; John Richie; Karen Steindorf; Marco Peluso; Kim Overvad; Ole Raaschou-Nielsen; Francoise Clavel-Chapelon; Jacob P Linseisen; Heiner Boeing; Antonia Trichopoulou; Domenico Palli; Vittorio Krogh; Rosario Tumino; Salvatore Panico; Hendrik B Bueno-De-Mesquita; Petra H Peeters; Eiliv Lund; Carlos A Gonzalez; Carmen Martinez; Miren Dorronsoro; Aurelio Barricarte; M Jose Tormo; Josèr Quiros; Antonio Agudo; Goran Berglund; Bengt Jarvholm; Sheila Bingham; Timothy J Key; Emmanuelle Gormally; Rodolfo Saracci; Rudolf Kaaks; Elio Riboli; Paolo Vineis
Journal:  Biomarkers       Date:  2010-02       Impact factor: 2.658

9.  Smoking, DNA adducts and number of risk DNA repair alleles in lung cancer cases, in subjects with benign lung diseases and in controls.

Authors:  Marco Peluso; Armelle Munnia; Sara Piro; Alessandra Armillis; Marcello Ceppi; Giuseppe Matullo; Riccardo Puntoni
Journal:  J Nucleic Acids       Date:  2010-10-04

Review 10.  Biomarkers of induced active and passive smoking damage.

Authors:  Maura Lodovici; Elisabetta Bigagli
Journal:  Int J Environ Res Public Health       Date:  2009-02-26       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.